Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[T]he fraternal interaction among fans from dozens of countries and the local public reminded us that isolationism is not the dominant sentiment among 349 million Americans.
Russia’s exit on November 7, 2023, from the Treaty on Conventional Armed Forces in Europe (CFE), with the U.S. and NATO partners suspending their participating in the treaty highlights real concerns.